Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-04 08:53 am Sale |
2024-12-31 | 13G | SmartKem, Inc. SMTK |
Orin Hirschman | 362,784 9.900% |
-17,417 (-4.58%) |
Filing History |
| 2025-02-03 8:07 pm Purchase |
2024-12-31 | 13G | SmartKem, Inc. SMTK |
Orin Hirschman | 380,201 9.900% |
243,264 (+177.65%) |
Filing History |
| 2025-01-31 4:05 pm Purchase |
2024-12-31 | 13G | Intellicheck, Inc. IDN |
Orin Hirschman | 1,617,696 8.200% |
18,743 (+1.17%) |
Filing History |
| 2025-01-31 4:05 pm Purchase |
2024-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Orin Hirschman | 4,200,577 8.400% |
1,093,782 (+35.21%) |
Filing History |
| 2025-01-31 4:05 pm Sale |
2024-12-31 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 206,396 8.500% |
-18,202 (-8.10%) |
Filing History |
| 2025-01-31 4:05 pm Unchanged |
2024-12-31 | 13G | LightPath Technologies, Inc. LPTH |
Orin Hirschman | 3,723,932 9.400% |
0 (Unchanged) |
Filing History |
| 2025-01-31 4:05 pm Purchase |
2024-12-31 | 13G | TELA Bio, Inc. TELA |
Orin Hirschman | 2,662,785 6.800% |
1,284,840 (+93.24%) |
Filing History |
| 2025-01-29 8:02 pm Purchase |
2024-12-31 | 13G | Elutia Inc. ELUT |
Orin Hirschman | 3,074,735 9.900% |
1,188,179 (+62.98%) |
Filing History |
| 2025-01-29 7:58 pm Purchase |
2024-12-31 | 13G | Biofrontera Inc. BFRI |
Orin Hirschman | 884,563 9.900% |
383,129 (+76.41%) |
Filing History |
| 2025-01-29 06:17 am Sale |
2024-12-31 | 13G | Immix Biopharma, Inc. IMMX |
Orin Hirschman | 0 0.000% |
-1,455,000 (Position Closed) |
Filing History |
| 2025-01-29 06:13 am Purchase |
2024-12-31 | 13G | Grace Therapeutics, Inc. GRCE |
Orin Hirschman | 521,083 5.100% |
521,083 (New Position) |
Filing History |
| 2025-01-29 06:11 am Sale |
2024-12-31 | 13G | Electrovaya Inc. ELVA |
Orin Hirschman | 2,515,099 6.300% |
-838,209 (-25.00%) |
Filing History |
| 2025-01-29 06:08 am Purchase |
2024-12-31 | 13G | Arq, Inc. ARQ |
Orin Hirschman | 3,012,956 7.200% |
674,220 (+28.83%) |
Filing History |
| 2025-01-27 10:07 am Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 67,407 4.900% |
-21,337 (-24.04%) |
Filing History |
| 2025-01-23 3:34 pm Sale |
2024-12-31 | 13G | BK Technologies Corporation BKTI |
Orin Hirschman | 268,180 7.500% |
-62,716 (-18.95%) |
Filing History |
| 2025-01-21 11:57 am Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Orin Hirschman | 2,717,827 6.100% |
2,717,827 (New Position) |
Filing History |
| 2024-11-08 4:51 pm Sale |
2024-11-05 | 13G | Delcath Systems, Inc. DCTH |
Orin Hirschman | 1,472,312 4.600% |
-67,326 (-4.37%) |
Filing History |
| 2024-10-29 7:47 pm Unchanged |
2024-10-29 | 13G | Evoke Pharma, Inc. EVOK |
Orin Hirschman | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-10-09 5:19 pm Purchase |
2024-10-01 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 224,598 9.300% |
146,775 (+188.60%) |
Filing History |
| 2024-10-09 4:05 pm Sale |
2024-10-02 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Orin Hirschman | 0 0.000% |
-1,061,509 (Position Closed) |
Filing History |